HEB Stock Analysis September 28, 2009 9/28/09

HEB Technical Analysis - The following is Hemispherx Biopharma, Inc. (HEB) stock technical analysis for September 28, 2009

Hemispherx Biopharma, Inc. (HEB) Support & Resistance Levels - 9/28/09

Resistance Levels: $2.25, $2.54

Support Levels: $2.00, $1.86

Chart - http://stockcharts.com/

Discuss Stocks - http://stockstobuy.org/

HEB stock continues to hover around the $2 level. The company expects the FDA to come out with a decision on their CFS drug sometime this fall.

Resistance is located around $2.24, if I see HEB close above $2.25, I will get back into the stock. This would be a huge trend reversal because HEB hasn't closed over $2.25 since July.

On the downside, pullbacks to $1.86 must continue to hold. For More Technical Analysis - Go Here

Today's Biggest Stock Market Gainers - Top 2009 Stock Gainers - Top 2009 Penny Stocks

For the latest updates on the stock market, visit, http://daytradingstockblog.blogspot.com/ or Subscribe for Free